Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Xingyi Lin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5050703401. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 5

  1. Corrigendum to "Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis" [Translational Resea… Co-author DOI 10.1016/j.trsl.2026.09.008↗
  2. Dynamic feedback between IL-6 and TWIST1 drives pancreatic cancer progression. Co-author DOI 10.21037/tgh-2026-0021↗
  3. Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer. Co-author DOI 10.1007/s00280-023-04616-6↗
  4. Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis. Co-author DOI 10.1016/j.trsl.2022.11.007↗
  5. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. Co-author DOI 10.1016/j.canlet.2022.215863↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guangsheng Ou · 5 shared papers, 2022–2026 · strength 1.18
  2. Zhenfeng Tian · 4 shared papers, 2022–2026 · strength 0.96
  3. Ying Tan · 3 shared papers, 2023–2026 · strength 0.74
  4. Yinting Chen · 2 shared papers, 2026 · strength 0.62
  5. Yinting Chen · 3 shared papers, 2022–2024 · strength 0.57
  6. Miao Yu · 1 shared paper, 2026 · strength 0.30
  7. Jinmao Zou · 1 shared paper, 2022 · strength 0.15
  8. Shangxiang Chen · 1 shared paper, 2022 · strength 0.15
  9. Yaqing Li · 1 shared paper, 2022 · strength 0.15
  10. Kaihong Huang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.